Atlas Trials

Papillomavirus Vaccines

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Papillomavirus Vaccines

RecordFirmDate
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers (NCT06854354)Hospital Univeristario Benemerita Universidad Autonoma de Puebla2021-12-07
Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination (NCT05148559)Huong Nguyen, PhD2021-08-12
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors (NCT04469569)University of Alabama at Birmingham2021-02-01
Changes in the Prevalence of Oncogenic HPV Types (NCT04671823)Kanazawa Medical University2020-12-01
Effectiveness of HPV Vaccine in Thai Adult Women (NCT03763565)Mahidol University2018-11-01
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination (NCT03350698)Eastern Virginia Medical School2018-04-06
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination (NCT03501992)Mayo Clinic2018-04-01
AFIX to Improve HPV Vaccination (NCT02370459)University of North Carolina, Chapel Hill2015-04-01
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females (NCT01031069)GlaxoSmithKline2010-10-26
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults (NCT00798265)National Cancer Institute (NCI)2009-06-29
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. (NCT00877877)GlaxoSmithKline2009-05-07
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299) (NCT00637195)GlaxoSmithKline2008-03-11
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age (NCT00423046)GlaxoSmithKline2007-01-24
Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine (NCT00359619)GlaxoSmithKline2006-09-12
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older (NCT00294047)GlaxoSmithKline2006-02-16
Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation. (NCT00250276)GlaxoSmithKline2005-10-28

Track Papillomavirus Vaccines automatically

Every clearance here is in the API, with alerts when new ones post.